A randomized study 17 even showed a trend in favour of GMA compared with steroids in mild to moderate forms of the disease (90% versus 75% of remission-response, respectively) with a reduction in side effects but with higher costs.
← all excerpts
Therapeutic landscape for ulcerative colitis: where is the Adacolumn(®) system and where should it be?
1
—
—